CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
Clinical trials for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN) explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN) trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
ED drug may shield cancer patients from Chemo's painful side effect
Prevention CompletedThis study tested if tadalafil, a medication also used for erectile dysfunction, could prevent nerve damage caused by a common prostate cancer chemotherapy. Researchers gave 90 men with advanced prostate cancer either tadalafil or standard care alongside their chemotherapy. They …
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC
-
Web workouts fight chemo nerve pain
Symptom relief CompletedThis study tested if an 8-week online exercise program could help reduce nerve pain and improve quality of life for breast cancer patients undergoing chemotherapy. 90 participants were randomly assigned to either follow the web-based program or receive usual care. The goal was to…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
Phase: NA • Sponsor: Bilecik Seyh Edebali Universitesi • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC